Evidence map›Paper›PMID 38107418›Full record

ArticleACS polymers Au2023

Intermediate Polymer Relaxation Explains the Anomalous Rheology of Nanocomposites with Ultrasmall Attractive POSS Nanoparticles.

Walter W Young, Reika Katsumata

Abstract read
In one paragraph

Article in ACS polymers Au, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Walter W YoungDepartment of Polymer Science and Engineering, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States.ORCID https://orcid.org/0000-0003-4358-9639
Reika KatsumataDepartment of Polymer Science and Engineering, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States.ORCID https://orcid.org/0000-0003-3119-9385

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rheological properties of entangled polymers loaded with very small, strongly attractive polyhedral oligomeric silsesquioxane (POSS) fillers differ from that of nanocomposites with larger fillers by (1) the shorter breadth of the entanglement plateau and (2) the relatively unchanged terminal viscosity with increasing POSS loading. Although such anomalous rheological properties can rewrite the property-processing map of materials (e.g., high glass transition temperature and low viscosity), their mechanism remains unclear. In this study, we report that polymer relaxations on intermediate time scales between α and entire-chain relaxation, so-called "slower processes", are responsible for this unusual rheological behavior of poly(2-vinylpyridine)/octa(aminophenyl)silsesquioxane (P2VP/OAPS) nanocomposites. To uncover the effects of entanglements on the nanocomposite dynamics, rheometry is used for variable matrix molecular weights. Results show a systematic change in the rheological response, which is independent of the molecular weight, and in turn, the presence of entanglements. This supports a physical interpretation that a slower process dominates the rheological response of the material at intermediate frequencies on length scales larger than the segment length or the OAPS diameter, while the underlying physical time scales associated with the entanglement relaxation remain unchanged. Such insights are anticipated to assist the future rational design of other highly attractive and ultrasmall nanoparticles that enable a fine-tuned rheological response of nanocomposites across multiple length scales.

Identifiers

PMID38107418
PMCPMC10722563

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.